Revision #1

A Company in Decline Eyes Its Biggest Deal Yet

Estée Lauder Companies, the 78-year-old beauty conglomerate behind Clinique, M.A.C, La Mer, and Tom Ford Beauty, confirmed on March 24, 2026 that it is in discussions with Spain's Puig — owner of Charlotte Tilbury, Carolina Herrera, and Jean Paul Gaultier — over a potential business combination that would create a luxury beauty group valued at approximately $40 billion [1][2]. The talks arrive at a moment of acute vulnerability for Estée Lauder: three consecutive fiscal years of revenue decline, a stock price down 78% from its January 2022 high of $374.20, and a restructuring plan that now calls for eliminating up to 10,000 positions worldwide [3][4].

The central question facing investors, employees, and the broader beauty industry is whether this deal represents a genuine strategic transformation or a distressed company reaching for scale as a substitute for fixing its core operations.

The Financial Wreckage

Estée Lauder's decline in numbers is stark. From a peak of $17.74 billion in fiscal 2022 revenue, the company has contracted to $14.33 billion in fiscal 2025 — a 19% drop over three years [5][6]. Net earnings collapsed 60% year-over-year in fiscal 2024 to $409 million, and the company posted a net loss of $156 million in its first quarter of fiscal 2025 [3].

Source: Estée Lauder 10-K Filings

Data as of May 1, 2026CSV

The market capitalization tells an even more dramatic story. At its peak in January 2022, Estée Lauder was worth roughly $134 billion. By mid-2025, that figure had cratered to approximately $29 billion — a destruction of more than $100 billion in shareholder value. A partial recovery has brought the market cap to around $41 billion as of May 2026, buoyed in part by the Puig merger speculation [7][8].

Source: Yahoo Finance / Market Data

Data as of May 8, 2026CSV

The balance sheet adds another layer of concern. Estée Lauder carries approximately $7.3 billion in long-term debt against $2.9 billion in cash, yielding a debt-to-equity ratio of 183.1% — up sharply from 107.5% five years ago [9]. The company has engaged J.P. Morgan to arrange an additional €5 billion ($5.4 billion) financing package for the Puig transaction, according to a report by Spanish newspaper Expansión [10].

For context, when Estée Lauder made its last major acquisition — the $1.45 billion purchase of Too Faced in November 2016 — the company was generating $11.26 billion in annual revenue, its stock was trading near all-time highs, and its debt-to-equity ratio was well below 100% [11].

What Puig Brings to the Table

Puig, a family-controlled Spanish company that went public in May 2024, recorded €5.04 billion ($5.5 billion) in revenue for 2025, up 7.8% on a like-for-like basis, with net profit of €594 million [12][13]. The company's portfolio of 17 global brands includes three of the world's top ten selling fragrances — Rabanne, Carolina Herrera, and Jean Paul Gaultier — and the fast-growing Charlotte Tilbury makeup and skincare line, which posted 26.5% sales growth in its final quarter of 2025 [13].

The strategic logic centers on fragrance. A merger would catapult Estée Lauder's fragrance market share from roughly 6% to 15%, placing it alongside L'Oréal's 16% share [1]. The deal is structured primarily as a stock swap, designed to preserve liquidity while ensuring both founding families — the Lauders and the Puigs — retain significant voting power [2].

But the deal's logic looks different from each side of the table. Estée Lauder, which has seen its core skincare and makeup categories shrink by 12% and 6% respectively in fiscal 2025 [6], gains a fast-growing fragrance and makeup business running at high margins. Puig, by contrast, absorbs a company in the midst of a painful restructuring — one that is simultaneously trying to shed up to 10,000 employees and stabilize declining brands.

The China Problem an Acquisition Cannot Solve

The single largest driver of Estée Lauder's revenue decline has been its heavy exposure to China and Asian travel retail. At its peak in 2021, Asia Pacific represented approximately 34% of total revenue — significantly higher than most Western competitors [3]. By fiscal 2024, Asia Pacific sales had fallen 16% from their 2021 peak to $4.89 billion [3].

The company invested $1 billion in a Japanese manufacturing facility in 2018 specifically to serve Chinese consumers; that plant now operates at reduced capacity [3]. Mainland China's luxury market shrank 18% to 20% in 2024 according to Bain & Company, falling back to 2020 levels [14]. Reported skincare net sales — the category most exposed to Chinese demand via brands like Estée Lauder and La Mer — decreased by $946 million in fiscal 2025 alone, with approximately $829 million of that decline driven by the Asia travel retail business [6].

A merger with Puig does not directly address this geographic concentration. Puig's revenue base is weighted toward Europe and the Americas, which provides some diversification. But it does not fix the underlying challenge: Estée Lauder's legacy brands have lost market share in their largest growth market, and no amount of fragrance acquisitions changes the demand curve for prestige skincare in Asia.

A Mixed Acquisition Track Record

Estée Lauder has acquired roughly 25 brands since 2000, with results that range from successful integrations to quiet shutdowns. The record raises questions about management's capacity to absorb yet another major deal.

The Too Faced acquisition ($1.45 billion, 2016) has generally been considered a success, with the brand maintaining relevance in prestige makeup [11]. But BECCA Cosmetics, acquired in 2016 for an estimated $200–300 million, was shut down entirely by September 2021 — less than five years after purchase [15]. The brand had been acquired specifically for its social media momentum and Gen-Z appeal, qualities that proved difficult to sustain under a corporate parent.

Other acquisitions have had mixed outcomes. Smashbox (acquired 2010) has been earmarked for divestiture along with Too Faced and Dr.Jart+ as new CEO Stéphane de La Faverie reassesses the portfolio [16]. Le Labo and Jo Malone have performed well in the fragrance category, but these acquisitions predate the company's current financial difficulties.

The pattern suggests Estée Lauder has been a better steward of niche fragrance brands than mass-market makeup acquisitions — which is, at least, consistent with the logic of a Puig fragrance merger.

Investor Dissent and Governance Concerns

The proposed merger has drawn pointed criticism from both sides. Puig investor Xavier Brun has argued publicly that "Estée Lauder would benefit more from Puig than Puig from Estée Lauder," citing Estée Lauder's sustained underperformance [17]. Other Puig shareholders have raised concerns about the deal contradicting the strategy Marc Puig had outlined to investors — a focus on acquiring smaller, niche beauty brands rather than a mega-merger with a struggling conglomerate [17].

Governance structures at both companies complicate matters. The Lauder family controls approximately 82% of voting power at Estée Lauder through dual-class shares, with Class B shares carrying 10 votes each versus one vote for publicly traded Class A shares [18]. The Puig family similarly controls 72% of equity and 93% of voting power through supervoting Class A shares [17]. This means minority shareholders on both sides have limited ability to block or meaningfully shape the deal.

The dual-class structure at Estée Lauder has also effectively deterred activist investors. Reports of potential interest from Nelson Peltz's Trian Partners surfaced but led nowhere, in part because the firm's dual-class share structure gives the Lauder family outsized control [19]. In January 2026, Leonard Lauder's family sold $1 billion worth of shares in a secondary offering, reducing the family's economic stake while maintaining voting control [20].

Estée Lauder's fiscal 2026 guidance projects reported sales growth of 3% to 5% and reported earnings per share between $0.98 and $1.22 [8] — modest targets that have not silenced skeptics who question whether the company can integrate a €5 billion acquisition while its core business is still in recovery mode.

How Rivals Are Playing the Same Downturn Differently

Estée Lauder's competitors have pursued sharply divergent strategies during the same period of beauty industry upheaval, and the comparison is instructive.

L'Oréal has been the most aggressive acquirer, but with a markedly different approach. Its €4 billion acquisition of Creed from Kering brought niche fragrance prestige; its acquisition of Medik8 for $1.1 billion targeted clinical skincare; and its accumulation of a 20% stake in Galderma for approximately €6 billion positioned the company in medical dermatology [21][22]. Each deal targeted a specific growth category rather than broad scale.

Coty, by contrast, is moving in the opposite direction — toward portfolio pruning. Under new CEO Markus Strobel, the company is conducting a strategic review of its $1.2 billion mass color cosmetics business and its $400 million Brazil operations, assessing partnerships, divestitures, and potential spin-offs. The looming loss of its Gucci license in 2028, which generates roughly $1.1 billion in annual sales, presents what analysts have described as an existential challenge [16].

e.l.f. Beauty made headlines with its $1 billion acquisition of Hailey Bieber's Rhode brand — a bet on celebrity-driven skincare at a fraction of the price Estée Lauder is contemplating for Puig [22].

The data does not clearly show that acquisition-led recovery outperforms portfolio optimization in prestige beauty. L'Oréal's acquisitions have worked because the company was operating from a position of financial strength; Coty's divestitures reflect a company trying to find focus after years of overleveraged deal-making. Estée Lauder sits uncomfortably between these two models.

The Human Cost: Up to 10,000 Jobs at Stake

The workforce implications are already substantial and could grow. In its May 1, 2026 third-quarter earnings release, Estée Lauder announced that it now expects total reductions of 9,000 to 10,000 positions — up from a prior estimate of 7,000 — aiming to save as much as $1.2 billion in costs [4][23]. At the upper end, that represents approximately 17.5% of its 57,000 global workforce as of June 30, 2025 [4].

The majority of the additional 2,000–3,000 cuts will target retail roles in department stores and freestanding stores as the company shifts toward digital and high-growth channels like Amazon and TikTok [4]. eMarketer analyst Sky Canaves noted that "the increase in planned job cuts could be an indication that in light of merger plans, Estee Lauder will be able to shed more positions on its side while retaining Puig employees" [23].

A completed merger would almost certainly create further redundancies in corporate functions — finance, human resources, supply chain, marketing — across both companies. Puig employs approximately 11,000 people globally [12]. Under U.S. federal law, the WARN Act requires 60 days' advance notice for mass layoffs affecting 100 or more employees at a single site. In the European Union, where Puig's operations are concentrated, the Acquired Rights Directive and national labor laws generally provide stronger protections, including mandatory consultation periods with employee representatives and, in Spain, social plans that can include enhanced severance.

No specific redundancy figures for a combined entity have been disclosed.

Endgame Scenarios if the Deal Fails — or Falters

If the Puig merger collapses or fails to reverse the sales trajectory within 24 months, several scenarios come into focus.

Portfolio breakup. CEO de La Faverie has already signaled willingness to divest brands, with Too Faced, Smashbox, and Dr.Jart+ reportedly under review [16]. A more aggressive breakup could see the company sell or spin off entire categories — shedding makeup brands to focus on its strongest properties in skincare (La Mer, Clinique) and fragrance (Tom Ford, Le Labo, Jo Malone).

Private equity interest. The Lauder family's dual-class share structure makes a hostile takeover functionally impossible, but a negotiated take-private transaction remains plausible if the family's economic interests continue to erode. The family's decision to sell $1 billion in shares in January 2026 has been interpreted by some analysts as a hedging move [20].

Strategic acquisition by a larger player. L'Oréal, LVMH, or Unilever could emerge as acquirers of individual Estée Lauder brands or — in a more dramatic scenario — of the company as a whole. L'Oréal's CEO Nicolas Hieronimus has shown a willingness to pursue large transactions [21], though antitrust concerns would be significant for a full combination.

Status quo restructuring. The most likely near-term outcome if the Puig deal fails: Estée Lauder continues its "Beauty Reimagined" restructuring plan, absorbs the cost savings from 10,000 job cuts, and attempts to ride a recovery in Chinese consumer spending that may or may not materialize [24].

Institutional shareholders are watching closely. Vanguard, BlackRock, and State Street collectively hold significant Class A positions [25], but their influence is limited by the Lauder family's voting control. The outcome will ultimately be determined by whether the Lauder family views the Puig merger as the best path to preserving both their financial stake and the company their grandmother founded in 1946.

What Happens Next

The Puig merger talks remain preliminary. Neither company has disclosed a timeline for a definitive agreement, and Puig CEO Jose Manuel Albesa confirmed during the company's Q1 2026 earnings call that "no agreement has been reached" [12]. J.P. Morgan's engagement to arrange financing suggests the deal is progressing beyond exploratory discussions, but significant hurdles remain — including regulatory review in the United States and European Union, potential divestitures to satisfy antitrust requirements, and the complex task of merging two family-controlled companies with different cultures, geographies, and operating models.

What is clear is that Estée Lauder's current trajectory is unsustainable. Revenue has declined for three consecutive years. The China recovery that management has repeatedly forecast has not materialized. The company is cutting nearly one in five employees. Whether a $40 billion merger with Puig is the right medicine — or simply a larger bet by a company that has been losing smaller ones — will depend on execution that Estée Lauder has not consistently demonstrated in its recent acquisition history.